Candicidin treatment of prostatism: A pr
β
Jensen, K. M.-E. ;Madsen, P. O.
π
Article
π
1983
π
Springer
π
English
β 385 KB
The polyene macrolide candicidin was investigated in the treatment of benign prostatic hyperplasia (BPH). Forty-one unselected patients with BPH and prostatism were admitted to a prospective, double-blind placebo-controlled clinical trial. Patients treated with 270 mg candicidin daily for 6 months h